CN Patent

CN1981044B — 包封干扰rna的脂质

Assigned to Wild Strawberry Bio Pharmaceutical Co · Expires 2010-05-05 · 16y expired

What this patent protects

本发明涉及将核酸-脂质颗粒递送，例如引入到细胞中的基于脂质的制剂，以及优化这些基于脂质的制剂的递送效率的测定法。所述核酸-脂质颗粒包括干扰RNA分子，具有超过一个不饱和位点的约10-约20个碳原子的烷基侧链的阳离子脂质，非阳离子脂质和抑制颗粒聚集的缀合的脂质诸如聚乙二醇(PEG)-脂质缀合物或聚酰胺(ATTA)-缀合物。

USPTO Abstract

本发明涉及将核酸-脂质颗粒递送，例如引入到细胞中的基于脂质的制剂，以及优化这些基于脂质的制剂的递送效率的测定法。所述核酸-脂质颗粒包括干扰RNA分子，具有超过一个不饱和位点的约10-约20个碳原子的烷基侧链的阳离子脂质，非阳离子脂质和抑制颗粒聚集的缀合的脂质诸如聚乙二醇(PEG)-脂质缀合物或聚酰胺(ATTA)-缀合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN1981044B
Jurisdiction
CN
Classification
—
Expires
2010-05-05
Drug substance claim
No
Drug product claim
No
Assignee
Wild Strawberry Bio Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.